Answers are grounded in this paper and cite their sources.
Explores diagnostic and therapeutic potential of Lu-FAPI-04 in rheumatoid arthritis, suggesting effective disease management.
OBJECTIVE: Fibroblast activation protein alpha (FAPα) plays a key role in cartilage degradation, inflammation, and bone erosion, particularly in rheumatoid arthritis (RA) where fibroblast-like synoviocytes in synovial tissue show elevated FAPα expression. This study explored radiolabeled FAP inhibitors for arthritis diagnosis and therapy. DESIGN: Lu-FAPI-04 targeted FAPα-expressing cells, and arthritis scores of treated CIA mice were compared with untreated controls using one-way ANOVA. RESULTS: Lu-FAPI-04 reduced arthritis scores by 64 % compared to controls (p < 0.005). CONCLUSION: Lu-FAPI-04 demonstrated therapeutic potential by mitigating disease activity, suggesting its promise for RA treatment.
No takes yet. Share an insight, caveat, or question.
Tseng et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: